Ophthalmology · Los Angeles, CA
NPI
1225072481
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4220 W 3rd St, Suite 206
Los Angeles, CA, 90020
Phone (213) 380-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
11,149 services
Medicare patients, 2024
954
Average age 80
Drug cost, 2024
$6.0M
21,125 prescriptions
Company payments, 2025
$4,434
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew S Cho was code 92012 (ophthalmological e&m), 1,617 times for 723 patients. In total Andrew S Cho billed 11,149 services in 57 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 1,617 | 723 | $75.42 | $122K |
| J0178 Injection, aflibercept, 1 mg | Office | 986 | 104 | $659.18 | $650K |
| 68761 Eye | Office | 951 | 614 | $181.23 | $172K |
| 92250 Angiography | Office | 878 | 710 | $28.84 | $25K |
| 92014 Ophthalmological E&M | Office | 794 | 647 | $99.36 | $79K |
| 92083 Vision, Hearing, and Speech Services | Office | 676 | 625 | $53.35 | $36K |
| 67028 Intravitreal Injection | Office | 552 | 109 | $49.01 | $27K |
| 65800 Fluid Flow and Drainage of Eye (Any Method) | Office | 550 | 112 | $100.35 | $55K |
| 92273 Test - Miscellaneous | Office | 547 | 460 | $111.07 | $61K |
| 68840 Eye | Office | 413 | 284 | $149.56 | $62K |
| 92235 Angiography | Office | 330 | 317 | $145.58 | $48K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 316 | 213 | $208.45 | $66K |
| 92134 Computerized Ophthalmic Imaging | Office | 185 | 129 | $35.13 | $6,499 |
| 67820 Eye | Office | 166 | 107 | $12.72 | $2,112 |
| 76513 Ultrasound - Nonspecific | Office | 143 | 141 | $64.56 | $9,232 |
By year: 2022 $2.1M for 15,128 services; 2023 $1.9M for 12,308 services; 2024 $1.7M for 11,149 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew S Cho prescribed most often to Medicare patients was Latanoprost, with 3,678 prescriptions and refills. In total Andrew S Cho wrote 21,125 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 3,678 | 6,575 | 872 | $33K |
| Restasis Cyclosporine | 3,485 | 4,848 | 970 | $3.0M |
| Timolol Maleate Generic | 2,452 | 4,699 | 630 | $22K |
| Cyclosporine Generic | 1,745 | 2,989 | 685 | $822K |
| Moxifloxacin Moxifloxacin Hcl | 1,168 | 1,172 | 491 | $26K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,093 | 2,267 | 283 | $19K |
| Vascepa Icosapent Ethyl | 804 | 1,075 | 149 | $369K |
| Ketorolac Tromethamine Generic | 801 | 1,226 | 646 | $8,228 |
| Azelastine Hcl Generic | 646 | 923 | 253 | $9,836 |
| Prednisolone Acetate Generic | 435 | 523 | 267 | $10K |
| Rhopressa Netarsudil Mesylate | 423 | 644 | 118 | $183K |
| Vyzulta Latanoprostene Bunod | 368 | 518 | 68 | $142K |
| Brimonidine Tartrate Generic | 341 | 609 | 104 | $37K |
| Alphagan P Brimonidine Tartrate | 313 | 467 | 74 | $89K |
| Miebo Perfluorohexyloctane/Pf | 262 | 381 | 71 | $269K |
Brand drugs: 10,334 claims; generic drugs: 10,791 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew S Cho $4,434 ($4,434 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $956.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 32 | $956 |
| Tarsus Pharmaceuticals, Inc. TARS | 14 | $611 |
| Nova Eye, Inc. | 1 | $508 |
| Lumenis BE inc | 1 | $480 |
| Alcon Vision LLC ALC | 10 | $339 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $327 |
| Bausch & Lomb Americas Inc. BLCO | 10 | $273 |
| Sight Sciences, Inc. SGHT | 3 | $206 |
| Axsome Therapeutics, Inc. AXSM | 1 | $148 |
| Novo Nordisk Inc NVO | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.